HAEMONETICS CORP - Common Stock (HAE)

Historical Holders from Q1 2014 to Q3 2025

Symbol
HAE on NYSE
Type / Class
Equity / Common Stock
Shares outstanding
47.9M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
51.3M
Holdings value
$2.5B
% of all portfolios
0.003%
Grand Portfolio weight change
0%
Number of holders
295
Number of buys
149
Number of sells
-170
Average Value change %
0%
Average buys %
+0.002%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of HAEMONETICS CORP - Common Stock (HAE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 4.6% -16% $166M -$36.4M 2.2M -18% Wellington Management Group LLP 30 Jun 2025
T. Rowe Price Investment Management, Inc. 4.4% $136M 2.2M T. Rowe Price Investment Management, Inc. 31 Mar 2025
Capital Research Global Investors 3.1% $97.7M 1.58M Capital Research Global Investors 31 Mar 2025

Institutional Holders of HAEMONETICS CORP - Common Stock (HAE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 51.3M $2.5B -$235M $48.74 295
2025 Q2 54.3M $4.05B +$51.1M $74.61 297
2025 Q1 53.7M $3.41B -$213M $63.55 313
2024 Q4 56.6M $4.42B +$40.4M $78.08 305
2024 Q3 55.9M $4.49B -$21M $80.38 303
2024 Q2 55.9M $4.62B +$386M $82.73 315
2024 Q1 51.2M $4.37B +$50.8M $85.35 296
2023 Q4 50.6M $4.33B -$21M $85.51 294
2023 Q3 50.8M $4.55B +$20.4M $89.58 294
2023 Q2 50.5M $4.3B +$14.2M $85.14 288
2023 Q1 50.4M $4.17B +$9.61M $82.75 294
2022 Q4 50.4M $3.96B -$107M $78.65 287
2022 Q3 51.8M $3.83B -$28.1M $74.03 260
2022 Q2 52.1M $3.39B +$49.7M $65.18 229
2022 Q1 51.6M $3.26B +$121M $63.22 225
2021 Q4 50.1M $2.66B -$87.2M $53.04 240
2021 Q3 50.7M $3.58B +$7.33M $70.59 239
2021 Q2 50.7M $3.38B -$52.6M $66.64 249
2021 Q1 50M $5.55B -$22.3M $111.01 288
2020 Q4 49.7M $5.9B +$13.6M $118.75 278
2020 Q3 49.4M $4.31B -$6.82M $87.25 261
2020 Q2 49.5M $4.44B -$134M $89.56 276
2020 Q1 50.6M $5.04B +$54.2M $99.66 263
2019 Q4 49.8M $5.73B -$8.41M $114.90 291
2019 Q3 49.6M $6.26B -$157M $126.14 271
2019 Q2 50.9M $6.12B +$58M $120.34 253
2019 Q1 51.3M $4.49B +$62.3M $87.48 253
2018 Q4 50.4M $5.05B -$148M $100.05 277
2018 Q3 51.7M $5.92B +$211M $114.58 289
2018 Q2 50.4M $4.52B -$185M $89.68 289
2018 Q1 52.6M $3.85B +$17.6M $73.16 254
2017 Q4 53.6M $3.12B -$26.1M $58.08 240
2017 Q3 54.8M $2.46B -$29.4M $44.87 203
2017 Q2 55.5M $2.19B +$31.1M $39.49 190
2017 Q1 54.6M $2.22B +$337M $40.57 176
2016 Q4 52.5M $2.11B +$26.3M $40.20 192
2016 Q3 51.8M $1.88B +$32.1M $36.21 176
2016 Q2 51M $1.48B -$32M $28.99 169
2016 Q1 51.3M $1.79B +$9.52M $34.98 160
2015 Q4 51.2M $1.65B -$35.5M $32.24 158
2015 Q3 52.1M $1.68B -$42.4M $32.32 168
2015 Q2 53.4M $2.21B -$15M $41.36 176
2015 Q1 53.8M $2.41B -$14.8M $44.92 166
2014 Q4 54.2M $2.03B +$29.5M $37.42 171
2014 Q3 53.1M $1.85B -$47.8M $34.92 168
2014 Q2 54.5M $1.92B +$19M $35.28 172
2014 Q1 54.2M $1.77B -$103M $32.59 187